INmune Bio files CORDStrom patent in U.S. after favorable PCT opinion

Go back to INmune Bio files CORDStrom patent in U.S. after favorable PCT opinion
(NASDAQ: INMB) Delayed: 2.19 +0.14 (6.83%)
Previous Close $2.05    52 Week High
Open $2.07    52 Week Low
Day High $2.22    P/E N/A 
Day Low $2.06    EPS
Volume 390,068